At Praetego, we are committed to addressing neurodegenerative diseases associated with aging. Praetego’s management team led the discovery and development of the Amadorins. Our clinicians are leaders in the field of neurology and neurodegeneration. Complimented by guidance from industry veterans, the Praetego team has extensive technical and operational experience in developmental stage drug companies.
